Swine Flu Vaccine Productions
Posted by admin | Posted in preparation | Posted on 06-07-2009
To discuss and make strong decisions to fight the widespread Swine Flu, the
World Health Organization set a meeting with the vaccine manufacturers
together with other health experts to stop the Swine Flu Outbreak.
Different Pharmaceutical companies are ready to begin making a Swine Flu
vaccine — but as the virus may alter, there are questions formed:
How much should they have to produce? How will the government distribute
the vaccines to the infected areas? Who should get it, babies, youngsters,
adults, men, women, pregnant?
Most flu vaccine companies mentioned that they can only make one vaccine at
a time: either seasonal flu vaccine or pandemic vaccine. Production takes
months and it is impossible to switch halfway through if health officials
make a mistake. Vaccine makers can make limited amounts of both seasonal
flu vaccine and pandemic vaccine — though not at the same time — but they
cannot make massive quantities of both because that exceeds manufacturing
capacity.
Even if we are in the modern era, still the health officials have a big
problem to solve the spreading of deadly swine flu is, and whether they
will need more seasonal flu vaccine or swine flu vaccine. Scientists are
not sure the effectiveness of a vaccine, if the swine flu will transmute.
Only two billion doses of swine flu vaccine could be produced annually
based on the estimation of World Health Organization officials, though the
first batches wouldn’t be available for four to six months.
A “seed stock” to make the vaccine, which should be ready and it will be
distributed to manufacturers worldwide so they can start producing the
vaccine is now on the go as the U.S. Centers for Disease Control and
Prevention works on. After the vaccine manufacturers get the seed stock,
they won’t know how many doses of vaccine they can make or how long that
would take.
Including vaccine producer, GlaxoSmithKline PLC, the World Health
Organization is under negotiation process to save some of their swine flu
vaccine for poorer nations. A couple of years ago members of the rich
nations like United States, Switzerland, France, Denmark, Canada and
Britain signed deals with the vaccine makers to guarantee them pandemic
vaccines as soon as they’re available.
Cipla (The pharmaceuticals giant in India) instructed by the World Health
Organization to make a generic version of Tamiflu antiviral drug. Tamiflu
also known as oseltamivir, one of the two antiviral drugs to treat the
Swine Flu. Then WHO said Cipla’s generic version was more effective than
the original made by Swiss firm Roche Holding AG and would hopefully make
the drug more accessible to the third world countries. As we all know that
Indian pharmaceuticals produce drugs in very affordable prices.
North America has been the hardest-hit continent for the Swine Flu virus
that kills two Americans from Texas (including a pregnant woman) and one in
Washington. If the vaccine productions are enough to all suspected Swine
Flu carrier, it won’t happen again that a simple pregnant woman died
fighting the virus.
Through this article, we will inform the public of an early planning and
prevention against Swine Flu for their safety. Consult to the Health
Officers about planning and prevention against the virus. According to an
unidentified source that one out of three Americans can only take the
Tamiflu.

